BRI-CHEM CORP (BRY.CA) Stock Fundamental Analysis
Canada - TSX:BRY - CA10778T1057 - Common Stock
0.225 CAD
+0.02 (+7.14%)
Overall BRY gets a fundamental rating of 1 out of 10. We evaluated BRY against 12 industry peers in the Trading Companies & Distributors industry. BRY has a bad profitability rating. Also its financial health evaluation is rather negative. BRY is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BRY has reported negative net income.
BRY had a positive operating cash flow in the past year.
In multiple years BRY reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: BRY reported negative operating cash flow in multiple years.
1.2 Ratios
BRY's Return On Assets of -3.96% is on the low side compared to the rest of the industry. BRY is outperformed by 91.67% of its industry peers.
BRY's Return On Equity of -10.89% is on the low side compared to the rest of the industry. BRY is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.96% | ||
| ROE | -10.89% | ||
| ROIC | N/A |
ROA(3y)1.89%
ROA(5y)-2.15%
ROE(3y)7.6%
ROE(5y)-2.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 16.70%, BRY is doing worse than 66.67% of the companies in the same industry.
BRY's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BRY so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.7% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.96%
GM growth 5Y-0.62%
2. Health
2.1 Basic Checks
BRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BRY has about the same amount of shares outstanding.
BRY has more shares outstanding than it did 5 years ago.
BRY has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.44, we must say that BRY is in the distress zone and has some risk of bankruptcy.
BRY has a worse Altman-Z score (1.44) than 91.67% of its industry peers.
BRY has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as BRY would need 2.95 years to pay back of all of its debts.
The Debt to FCF ratio of BRY (2.95) is better than 75.00% of its industry peers.
A Debt/Equity ratio of 0.98 indicates that BRY is somewhat dependend on debt financing.
BRY has a Debt to Equity ratio of 0.98. This is amonst the worse of the industry: BRY underperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.98 | ||
| Debt/FCF | 2.95 | ||
| Altman-Z | 1.44 |
ROIC/WACCN/A
WACC8.5%
2.3 Liquidity
BRY has a Current Ratio of 1.41. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.
BRY's Current ratio of 1.41 is on the low side compared to the rest of the industry. BRY is outperformed by 75.00% of its industry peers.
BRY has a Quick Ratio of 1.41. This is a bad value and indicates that BRY is not financially healthy enough and could expect problems in meeting its short term obligations.
BRY's Quick ratio of 0.69 is on the low side compared to the rest of the industry. BRY is outperformed by 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The earnings per share for BRY have decreased strongly by -16.35% in the last year.
BRY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.74%.
Measured over the past years, BRY shows a decrease in Revenue. The Revenue has been decreasing by -1.96% on average per year.
EPS 1Y (TTM)-16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.89%
Revenue 1Y (TTM)-11.74%
Revenue growth 3Y11.21%
Revenue growth 5Y-1.96%
Sales Q2Q%7.49%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BRY. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRY is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
BRY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRY is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.89 | ||
| EV/EBITDA | 18.73 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BRY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:BRY (11/14/2025, 7:00:00 PM)
0.225
+0.02 (+7.14%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.8%
Ins Owner ChangeN/A
Market Cap5.95M
Revenue(TTM)83.04M
Net Income(TTM)-2.11M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.07 | ||
| P/FCF | 0.89 | ||
| P/OCF | 0.85 | ||
| P/B | 0.31 | ||
| P/tB | 0.31 | ||
| EV/EBITDA | 18.73 |
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.25
FCFY112.37%
OCF(TTM)0.26
OCFY117.04%
SpS3.14
BVpS0.73
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.96% | ||
| ROE | -10.89% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.7% | ||
| FCFM | 8.05% |
ROA(3y)1.89%
ROA(5y)-2.15%
ROE(3y)7.6%
ROE(5y)-2.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.96%
GM growth 5Y-0.62%
F-Score2
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.98 | ||
| Debt/FCF | 2.95 | ||
| Debt/EBITDA | 27.29 | ||
| Cap/Depr | 22.35% | ||
| Cap/Sales | 0.33% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 994.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 1.44 |
F-Score2
WACC8.5%
ROIC/WACCN/A
Cap/Depr(3y)93.13%
Cap/Depr(5y)56.73%
Cap/Sales(3y)1.06%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.74%
Revenue growth 3Y11.21%
Revenue growth 5Y-1.96%
Sales Q2Q%7.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-120.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y319.1%
FCF growth 3YN/A
FCF growth 5Y-15.31%
OCF growth 1Y928.61%
OCF growth 3YN/A
OCF growth 5Y-14.89%
BRI-CHEM CORP / BRY.CA FAQ
Can you provide the ChartMill fundamental rating for BRI-CHEM CORP?
ChartMill assigns a fundamental rating of 1 / 10 to BRY.CA.
What is the valuation status of BRI-CHEM CORP (BRY.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to BRI-CHEM CORP (BRY.CA). This can be considered as Overvalued.
What is the profitability of BRY stock?
BRI-CHEM CORP (BRY.CA) has a profitability rating of 1 / 10.